EP0944394A4 - Traitement de l'infection a vih par action sur le recepteur de la cyclophiline de cellules hotes - Google Patents

Traitement de l'infection a vih par action sur le recepteur de la cyclophiline de cellules hotes

Info

Publication number
EP0944394A4
EP0944394A4 EP97917517A EP97917517A EP0944394A4 EP 0944394 A4 EP0944394 A4 EP 0944394A4 EP 97917517 A EP97917517 A EP 97917517A EP 97917517 A EP97917517 A EP 97917517A EP 0944394 A4 EP0944394 A4 EP 0944394A4
Authority
EP
European Patent Office
Prior art keywords
hiv
interfering
infection
treatment
host cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97917517A
Other languages
German (de)
English (en)
Other versions
EP0944394A1 (fr
Inventor
Michael Bukrinsky
Barbara A Sherry
Peter C Ulrich
Anthony Cerami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Picower Institute for Medical Research
Original Assignee
Picower Institute for Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/615,933 external-priority patent/US5840305A/en
Application filed by Picower Institute for Medical Research filed Critical Picower Institute for Medical Research
Publication of EP0944394A1 publication Critical patent/EP0944394A1/fr
Publication of EP0944394A4 publication Critical patent/EP0944394A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/52—Isomerases (5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP97917517A 1996-03-12 1997-03-12 Traitement de l'infection a vih par action sur le recepteur de la cyclophiline de cellules hotes Withdrawn EP0944394A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1318596P 1996-03-12 1996-03-12
US613185P 1996-03-12
US08/615,933 US5840305A (en) 1996-03-14 1996-03-14 Treatment of HIV-Infection by interfering with host cell cyclophilin receptor activity
US615933 1996-03-14
PCT/US1997/003819 WO1997033604A1 (fr) 1996-03-12 1997-03-12 Traitement de l'infection a vih par action sur le recepteur de la cyclophiline de cellules hotes

Publications (2)

Publication Number Publication Date
EP0944394A1 EP0944394A1 (fr) 1999-09-29
EP0944394A4 true EP0944394A4 (fr) 2003-05-14

Family

ID=26684543

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97917517A Withdrawn EP0944394A4 (fr) 1996-03-12 1997-03-12 Traitement de l'infection a vih par action sur le recepteur de la cyclophiline de cellules hotes

Country Status (5)

Country Link
EP (1) EP0944394A4 (fr)
JP (1) JP2000510097A (fr)
AU (1) AU723905B2 (fr)
CA (1) CA2248192A1 (fr)
WO (1) WO1997033604A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2461740C (fr) 2001-10-19 2013-02-12 Isotechnika Inc. Synthese d'analogues de cyclosporine
AU2002347102A1 (en) * 2001-10-25 2003-05-12 Hans Will Means for inhibition of the synthesis of viral proteins
US7108988B2 (en) 2001-11-02 2006-09-19 The J. David Gladstone Institutes Methods of identifying agents for inhibiting lentivirus replication
WO2016054354A1 (fr) * 2014-10-02 2016-04-07 Dana-Farber Cancer Institute, Inc. Compositions et méthodes pour le traitement de tumeurs malignes
CN112888452A (zh) * 2018-08-22 2021-06-01 贝凯恩生物医疗技术有限公司 环孢菌素组合物及使用方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0484281A2 (fr) * 1990-11-02 1992-05-06 Sandoz Ltd. Cyclosporines
WO1993023081A1 (fr) * 1992-05-15 1993-11-25 The Rockefeller University Procedes et agents pour moduler la reponse immunitaire, et leurs utilisations
WO1995007468A1 (fr) * 1993-09-08 1995-03-16 Sandoz Ltd. Coffret de dosage

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0484281A2 (fr) * 1990-11-02 1992-05-06 Sandoz Ltd. Cyclosporines
WO1993023081A1 (fr) * 1992-05-15 1993-11-25 The Rockefeller University Procedes et agents pour moduler la reponse immunitaire, et leurs utilisations
WO1995007468A1 (fr) * 1993-09-08 1995-03-16 Sandoz Ltd. Coffret de dosage

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ALLAIN F ET AL: "Selective assay for CyPA and CyPB in human blood using highly specific anti-peptide antibodies", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 178, no. 1, 13 January 1995 (1995-01-13), pages 113 - 120, XP004021130, ISSN: 0022-1759 *
BILLICH A ET AL: "MODE OF ACTION OF SDZ NIM 811, A NONIMMUNOSUPPRESSIVE CYCLOSPORIN A ANALOG WITH ACTIVITY AGAINST HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 1: INTERFERENCE WITH HIV PROTEIN-CYCLOPHILIN A INTERACTIONS", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 69, no. 4, 1 April 1995 (1995-04-01), pages 2451 - 2461, XP002022423, ISSN: 0022-538X *
ROYDON PRICE E ET AL: "CYCLOPHILIN B TRAFFICKING THROUGH THE SECRETORY PATHWAY IS ALTERED BY BINDING OF CYCLOSPORIN A", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 91, April 1994 (1994-04-01), pages 3931 - 3935, XP002931337, ISSN: 0027-8424 *
See also references of WO9733604A1 *

Also Published As

Publication number Publication date
AU723905B2 (en) 2000-09-07
JP2000510097A (ja) 2000-08-08
EP0944394A1 (fr) 1999-09-29
CA2248192A1 (fr) 1997-09-18
WO1997033604A1 (fr) 1997-09-18
AU2581197A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
EP0810864A4 (fr) 2,6-diarylpyridazinones a activite immunosuppressive
ZA986020B (en) Skin pricker
HU9702242D0 (en) Inozitol-glykanes of inzulin-like activity
ZA964880B (en) Pain cell line
IL128517A (en) Dihydropyrones with improved antiviral activity
EP0944394A4 (fr) Traitement de l'infection a vih par action sur le recepteur de la cyclophiline de cellules hotes
GB9512529D0 (en) Cell treatment
IL129576A0 (en) Mouse cardiac muscle cell line hl-1
EP0948254A4 (fr) Regulation cellulaire utilisee pour confirmer une activite enzymatique
AU2104497A (en) Cell stimulation
AU5926998A (en) Treatment of diabetes with synthetic beta cells
PL331855A1 (en) Biological reactor
GB9625941D0 (en) Anthraquinones with biological activity
AU8999298A (en) Protein having activity of activiting nerve cell functions
EP1107774A4 (fr) Ramp2a: proteine 2a modifiant l'activite d'un recepteur
AUPN190695A0 (en) Compounds with steroid-like activity
AUPN889996A0 (en) Compounds with steroid-like activity
TW329668U (en) Therapeutic elastic body support
GB9603850D0 (en) Triterpene derivatives with immunosuppressant activity
GB9605161D0 (en) Triterpene derivatives with immunosuppressant activity
GB9609665D0 (en) Triterpine derivatives with immunosuppressant activity
GB9501084D0 (en) Novel heterocyclic compounds with antitumoral,antiviral,and/or inmunomodulatory activity
PL318745A1 (en) Electrode for reducing bioelectric potential especially with animals
AUPO604897A0 (en) Compounds with steroid-like activity
TW339513U (en) Improved structure of an incubator

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030402

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 39:00 K

Ipc: 7A 61K 39/39 K

Ipc: 7A 61K 38:13 J

Ipc: 7A 61K 47/48 J

Ipc: 7A 61K 47/48 B

Ipc: 7C 12N 9/90 B

Ipc: 7A 61K 39/39 B

Ipc: 7A 61K 39/395 B

Ipc: 7A 61K 38/13 A

17Q First examination report despatched

Effective date: 20031023

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050719